About: Myasthenia gravis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Myasthenia gravis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1994

Attributes	Values
rdf:type	Item
description	наукова стаття, опублікована в червні 1994 (uk) im Juni 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1994 (ast) scientific article published on 01 June 1994 (en) 1994年6月1日に発表された論文 (ja)
publication date	wds:Q72436386-787B24EC-9B2D-4993-BF41-16DC6D7642F0
publication date	1994-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72436386-B4907E9D-8111-49E5-84E4-E2156B4D4525
language of work or name	English
author name string	wds:Q72436386-C12713FE-79CF-49A6-9893-1B40AA5390CD
author name string	Drachman DB
rdfs:label	Myasthenia gravis (en) 重症筋無力症 (ja)
skos:prefLabel	Myasthenia gravis (en) 重症筋無力症 (ja)
name	Myasthenia gravis (en) 重症筋無力症 (ja)
title	wds:Q72436386-AB81113F-CC28-479C-A2EA-EC8F505751A7
title	Myasthenia gravis (en)
page(s)	wds:Q72436386-E9A8E8A3-6583-40E1-AEA4-6B85C4EEAF5E
page(s)	1797-1810
instance of	wds:Q72436386-594a5413-14ca-4736-b777-7e45ef986f92 wds:Q72436386-AFCD1B80-7CB7-4FB3-B168-CAB8E564C135
instance of	review article scholarly article
main subject	wds:Q72436386-65352aad-4dcd-866b-c382-047751003d0e
main subject	myasthenia gravis
PubMed ID	wds:Q72436386-F619CC87-8C65-4ECB-98B1-887F1411A949
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8190158
PubMed ID	8190158
published in	wds:Q72436386-B39E3236-6957-4563-8A82-ED2690F4CF93
published in	The New England Journal of Medicine
issue	wds:Q72436386-6B686721-AB17-47FE-8906-D675383FECC2
volume	wds:Q72436386-B06EBA9A-EF89-445C-8C93-AFDEFF35E3DB
issue	25
volume	330
DOI	wds:Q72436386-47BCAD86-A0DA-4755-A7A1-22BD66E2CDE9
DOI	http://dx.doi.org/10.1056/NEJM199406233302507
DOI	10.1056/NEJM199406233302507
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72436386
is cites work of	A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases Neuromyelitis optica pathogenesis and aquaporin 4 Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies Associated autoimmune diseases in patients with multifocal motor neuropathy and their family members T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis Diagnosis and management of autoimmune myasthenia gravis Glutamate receptor GluR3 antibodies and death of cortical cells IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status Antigen processing and presentation by a murine myoblast cell line Preoperative preparation and anesthetic management of patients with myasthenia gravis Nicotinic Acetylcholine Receptors of Muscles and Nerves Nicotinic acetylcholine receptors in health and disease Therapeutic approaches to ion channel diseases The Role of Thymomas in the Development of Myasthenia Gravis Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report Update on myasthenia gravis Myasthenia gravis Therapeutic options in ocular myasthenia gravis Ocular myasthenia gravis: response to long-term immunosuppressive treatment Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss. Steroids and immunosuppressant drugs in myasthenia gravis Life-threatening misdiagnosis of bulbar onset myasthenia gravis as a motor neuron disease: How much can one rely on exaggerated deep tendon reflexes Follicular Helper CD4+ T Cells in Human Neuroautoimmune Diseases and Their Animal Models Serum cytokine and chemokine profiles in patients with myasthenia gravis Genetics of autoimmune myasthenia gravis, a model for antibody-mediated autoimmunity in man. Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Results of video-assisted thymectomy in patients with myasthenia gravis Video-assisted thoracoscopic management of mediastinal tumors Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies. Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+T cells A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravis Selective IgA deficiency in autoimmune diseases Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice Pathogenic autoantibodies to neuronal proteins in neurological disorders Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis Autoimmunity to gephyrin in Stiff-Man syndrome The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy Paraneoplastic neurologic syndromes Neuromuscular disorders in the intensive care unit An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus Some workmen can blame their tools: artistic change in an individual with Alzheimer's disease Human T follicular helper (Tfh) cells and disease Neuronal Ganglionic Acetylcholine Receptor Autoimmunity Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis Genetic association of Ctla-4 to myasthenia gravis with thymoma.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software